Mitchell A. Medland Jr., MHA, MBA, Celebrated for Contributions to the Pharmaceutical Industry
Press Release September 5, 2025
Mitchell A. Medland Jr., MHA, MBA, is the Vice President and General Manager of Breast & Women's Cancers at Novartis
img img
In 2024, he was named one of Pharmaceutical Executive Magazine's Pharma Marketing Top Movers and Shakers.

VALENCIA, CA, September 05, 2025 /24-7PressRelease/ -- Mitchell A. Medland Jr., MHA, MBA, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mr. Medland has established a distinguished career in the pharmaceutical and health care industries, marked by progressive leadership roles and significant contributions to public health. In 2024, he assumed the position of Vice President and General Manager of Breast and Women's Cancers at Novartis. In this capacity, he is responsible for leading strategic planning, developing market strategies, leading and collaborating with cross-functional teams, driving growth, and managing performance to align with the company's overall vision. His responsibilities also include analyzing and understanding market trends, developing innovative strategies for product portfolios, partnering with various internal and external stakeholders, and building and leading high-performing teams.

Before joining Novartis, Mr. Medland served as Vice President and Global Antiviral Lead and U.S. Antiviral Lead at Pfizer from 2021 to 2024. During this period, he played a pivotal role in building and leading the commercial organization to launch Paxlovid under the Emergency Use Authorization during the COVID-19 pandemic. Under his leadership, Paxlovid became one of the most widely used pharmaceutical products in history, treating over 10 million patients within two years and achieving a 90 percent market share in the United States. His efforts contributed to Pfizer's revenue growth and supported global efforts to return to normalcy by driving awareness and education about the availability of an effective treatment option for COVID-19. Mr. Medland collaborated closely with both federal and state government agencies while in these roles including members of the Biden administration.

During the preceding year, Mr. Medland held the role of Vice President of the U.S. Specialty Brands portfolio at Pfizer, overseeing a range of specialty pharmaceutical products and leading cross-functional teams to deliver business objectives. He also served as the Senior Director of Business Operations, supporting Pfizer's Hospital business unit's Global President.

Mr. Medland's earlier tenure at Pfizer, which began in 2005, included serving in a variety of commercial, marketing, operations, and sales leadership roles spanning multiple disease and therapeutic areas, including but not limited to Primary Care, Oncology, Cardiology, Urology, and Pain Management.

Before entering the pharmaceutical sector, Mr. Medland built foundational experience in telecommunications with Sprint Nextel. He served as District Business Manager from 2004 to 2005 after holding roles as Retail Store Manager, Indirect Account Executive and Senior Sales Representative.

Throughout his career, Mr. Medland has earned numerous accolades recognizing his leadership and dedication to excellence. In 2024, he was named one of Pharmaceutical Executive Magazine's Pharma Marketing Top Movers and Shakers and received both the Integrated Product Strategy Team of the Year and Performance Vigilance Team of the Year awards from Novartis. His achievements at Pfizer include the Biopharma Breakthrough Superstars Award in 2022, the Premier Performance Award and Be Greater Than Oncology Award in 2017 and the Bruce Haskitt Leadership Award in 2012, as well as the PM360 ELITE Leader of the Future Award. Earlier in his career, he earned the Pinnacle Club Platinum honor from Sprint PCS for being one of the nation's top sales representatives and was inducted into both the USC Chapter of Upsilon Phi Delta National Honor Society and the Honor Society of Phi Kappa Phi.

Mr. Medland's academic background reflects a dedication to lifelong learning inspired by his mother's example as a first-generation graduate who returned to school later in life. In his own journey, he earned a Master of Health Administration from the University of Southern California in 2014 and a Master of Business Administration at the University of Maryland Global Campus in Adelphi in 2012. His foundational work earned him a Bachelor of Science in Business Administration with a concentration in marketing from the University of California, Riverside.

Reflecting on his career, Mr. Medland attributes much of his professional success to his high learning agility, intellectual curiosity, and ability to adapt his leadership style to fit the specific needs of a given situation and his team. He also emphasizes that his three foundational pillars that serve as his north star are purpose, people and culture: obsessing over patient outcomes and prioritizing service to others above personal gain. This approach has shaped his ability to build high-performing teams where each member understands their role and is empowered to excel.

Furthering his professional network, Mr. Medland is an active mentor to many and an active member of several organizations, such as the University of Southern California Chapter of Upsilon Phi Delta National Honor Society, the Honor Society of Phi Kappa Phi and American College of Healthcare Executives. Beyond his professional pursuits, he values time spent with his family, including his wife and three children, as well as traveling, working out, golfing, enjoying nature and spending time with their dog. He finds balance by disconnecting from work when possible.

Looking ahead, Mr. Medland aims to continue growing as a leader within the industry, with aspirations to further advance, make even greater impact, and continue to demonstrate his ability to lead at scale. Throughout his life, he has remained focused on being present in the moment, appreciating the journey, and relentlessly pursuing growth and improvement every day in service of a vision of a better tomorrow.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #

Contact Information

-- --

Marquis Who's Who Ventures LLC

Uniondale, NY

USA

Telephone: 844-394-6946

Email: Email Us Here

Website: Visit Our Website

Follow Us: fb in x